A new approach to generating large quantities of myeloid progenitor cells ex vivo will facilitate detailed studies of normal white blood cell differentiation and of abnormalities leading to blood disorders such as leukemia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Katie Ris
References
Liebermann, D.A. & Hoffman, B. Stem cells 12, 352–369 (1994).
Rosmarin, A.G., Yang, Z. & Resendes, K.K. Exp. Hematology 33, 131–143 (2005).
Wang G., et al. Nat. Methods 3, 287–293 (2006).
Seely, A.J., Pascual, J.L. & Christou, N.V. Crit. Care 7, 291–307 (2003).
Tenen, D.G. Nat. Rev. Cancer 3, 89–101 (2003).
Pineault, N. et al. Exp. Hematol. 30, 49–57 (2002).
Calvo, K.R. et al. Mol. Cell. Biol. 20, 3274–3285 (2000).
Knoepfler, P.S. et al. Oncogene 20, 5440–5448 (2001).
Lawson, N.D., Krause, D.S. & Berliner, N. Exp. Hematol. 26, 1178–1185 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liebermann, D., Hoffman, B. Myeloid progenitors on demand. Nat Methods 3, 248–249 (2006). https://doi.org/10.1038/nmeth0406-248
Issue Date:
DOI: https://doi.org/10.1038/nmeth0406-248
